ECS on MSP
Expert Insight into the Latest News & Updates for Medicare Secondary Payer Compliance

Ask Annie: SSDI and Medicare’s “Reasonable Expectation” Analysis
Question: Annie, in ExamWorks’ last webinar, Marty and Christie discussed CMS’ updated guidance for cases that don’t meet review thresholds. I’ve heard from some people that

Appeals Court Declares CIGA Largely Exempt from Medicare Secondary Payer
The Ninth Circuit Court of Appeals ruled yesterday that the California Insurance Guaranty Association (CIGA) is not a “primary payer under the Medicare Act’s secondary

Ask Annie: Mysterious Conditional Payment Demands
This new column highlights practical ways to resolve critical Medicare Secondary Payer compliance questions. Annie Davidson and other ExamWorks experts will answer common and topical MSP

Addition of Open Debt Report Function the MSP Recovery Portal
Earlier today, The Centers for Medicare & Medicaid Services (CMS) announced the addition of an Open Debt Report function to the Medicare Secondary Payer Recovery Portal (MSPRP).

Ask Annie: Converting Lyrica to Pregabalin in a Medicare Set-Aside
This week we are starting a new feature to highlight practical ways to resolve critical Medicare Secondary Payer compliance questions. Annie Davidson (and occasionally other

CRC Clarifies Position on Filing Disputes
The Commercial Repayment Center (CRC) recently updated internal guidance regarding the treatment of Conditional Payment Letters (CPL) and clarified the process for filing disputes. The

MSP Recovery Takes a Hit
Thanks to an aggressive litigation strategy pursued over the course of the last decade, Medicare Advantage Plans have become a fixture of Medicare Secondary Payer

COMP Act Introduced in U.S. House
It is that time of year when we alert you to a Workers’ Compensation Medicare Set-Aside bill in Congress. Rep. Mike Thompson (D-CA) introduced H.R. 4161 on

NEWS FLASH – Price Drop for oxycodone/APAP 7.5-325mg and 10-325mg!
A widely used opioid-acetaminophen combination product, oxycodone/APAP 7.5-325mg and 10-325mg, has seen a significant drop in price! This will dramatically mitigate the Part D allocation
Ready to talk?
Schedule a conversation with an ECS expert